Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990-2019).
Florine L BoerVincent K Y HoMarieke W J LouwmanAnne M R SchraderCharlotte L ZuurChristian U BlankMariette I E van PoelgeestEllen H W KapiteijnPublished in: Cancers (2023)
Since the introduction of immune and targeted therapies, OS has improved for patients with MM. However, the prognosis of MM patients is still lower compared to CM, and the median OS of patients treated with immune and targeted therapies remains fairly short. Further studies are needed to improve outcomes for patients with MM.